Trial Site Detail

 

Drug:
QINLOCK Ripretinib DCC-2618 SUTENT Sunitinib
Trial:
A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (intrigue)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Active, not recruiting

 

Robert Lurie Comp. Cancer Center Northwestern University Hospital

675 North St. Clair     
Chicago , IL 60611
USA

 

Principal Investigator:
Mark Agulink
Contact:
Mark Agulink
Activation Status of this Site:
Active
Notes about this Site:
Robert Lurie Comp. Cancer Center Northwestern University Hospital Website:
http://www.cancer.northwestern.edu/public/why_northwestern/clinical_trials/index.cfm

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.